NG
Nathaniel Goss
General Practice
Credentials: ·
History
- 2023–2026
Residency
- 2019–2023
Medical School
Research
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
Nature Medicine · 2020 · 126 citations
Harm Reduction Journal · 2022 · 22 citations
Substance Use & Misuse · 2021 · First of 15 authors · 19 citations

3 papers

3 papers
- AF
2 papers

2 papers
- DM
2 papers

1 paper · 1 as a resident
- AC
1 paper

1 paper


